£76.38

Springer Endocrine Therapy of Breast Cancer VI (ESO Monographs)

Price data last checked 51 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£76 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 32 days · 32 data points (no recent data)

Historical
Generating forecast…
£76.38 £72.56 £74.09 £75.62 £77.14 £78.67 £80.20 01 May 2026 08 May 2026 16 May 2026 24 May 2026 01 June 2026

Price Distribution

Price distribution over 32 days • 1 price levels

Days at Price
32 days 0 8 16 24 32 £76 Days at Price

Price Analysis

Most common price: £76 (32 days, 100.0%)

Price range: £76 - £76

Price levels: 1 different prices over 32 days

Description

This is the sixth issue of the Monograph on various aspects of the EndocrineTherapy of Breast Cancer. The monograph includes a broad spectrum of issues including aspects of breast cancer, prevention and molecular genetics, autocrine and paracrine growth factors, the molecular biology of the oestrogen receptor and methods of abrogating endocrine resistance and new aspects of the therapy with antioestrogens and antiprogestogens. There are also chapters on aspects of immunotherapy and adjuvant chemo-endocrine therapy and quality of life issues. Special importance is given to the biological basis of the affects of endocrine therapy. Inaddition to novel endocrine treatments the affects of combined chemotherapy and endocrine therapy in the adjuvant situation are discussed. Breast cancer continues to represent an enormous challenge both to the basic scientist and to the clinical researcher. The latest issue of the European School of Oncology Monograph will be helpful in promoting cross fertilisation between the basic and applied disciplines.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
16 January 2012
Listed Since
12 July 2012

Barcode

No barcode data available

Similar Products You Might Like

Breast Cancer Management for Surgeons: A European Multidisciplinary Textbook
86% match

Breast Cancer Management for Surgeons: A European Multidisciplinary Textbook

Springer

£162.32 22 May 2026
Hormone Receptors in Breast Cancer: 147 (Cancer Treatment and Research, 147)
84% match

Hormone Receptors in Breast Cancer: 147 (Cancer Treatment and Research, 147)

Springer

£80.64 18 May 2026
Diet and the Aetiology of Cancer (ESO Monographs)
83% match

Diet and the Aetiology of Cancer (ESO Monographs)

Springer

£74.06 13 Jun 2026
Retinoids in Oncology (ESO Monographs)
83% match

Retinoids in Oncology (ESO Monographs)

Springer

£113.93 24 May 2026
Prognostic variables in node-negative and node-positive breast cancer
83% match

Prognostic variables in node-negative and node-positive breast cancer

Springer

£174.86 26 May 2026
Endocrine Therapies in Breast and Prostate Cancer: 39 (Cancer Treatment and Research, 39)
83% match

Endocrine Therapies in Breast and Prostate Cancer: 39 (Cancer Treatment and Research, 39)

Springer

£113.76 26 May 2026
Adjuvant Therapy of Breast Cancer V: 140 (Recent Results in Cancer Research, 140)
82% match

Adjuvant Therapy of Breast Cancer V: 140 (Recent Results in Cancer Research, 140)

Springer

£78.01 28 Jun 2026
The Etiology of Human Breast Cancer: Endocrine, Genetic, Viral, Immunologic and Other Considerations
82% match

The Etiology of Human Breast Cancer: Endocrine, Genetic, Viral, Immunologic and Other Considerations

Springer

£77.23 22 May 2026
New Approaches in Cancer Pharmacology: Drug Design and Development: Vol. II: 2 (ESO Monographs)
82% match

New Approaches in Cancer Pharmacology: Drug Design and Development: Vol. II: 2 (ESO Monographs)

Springer

£77.83 31 May 2026
Breast Cancer: Biological and Clinical Progress: Proceedings of the Conference of the International Association for Breast Cancer Research, St. ... 1991: 69 (Developments in Oncology, 69)
82% match

Breast Cancer: Biological and Clinical Progress: Proceedings of the Conference of the International Association for Breast Cancer Research, St. ... 1991: 69 (Developments in Oncology, 69)

Springer

£113.94 29 Jun 2026
Adjuvant Therapy of Breast Cancer: 60 (Cancer Treatment and Research, 60)
82% match

Adjuvant Therapy of Breast Cancer: 60 (Cancer Treatment and Research, 60)

Springer

£149.65 26 May 2026
Optimizing Breast Cancer Management: 173 (Cancer Treatment and Research, 173)
82% match

Optimizing Breast Cancer Management: 173 (Cancer Treatment and Research, 173)

Springer

£103.24 06 Jun 2026
A Practical Guide to Breast Cancer Treatment
82% match

A Practical Guide to Breast Cancer Treatment

Springer

£111.72 21 May 2026
Endocrine Therapies in Breast and Prostate Cancer: 39 (Cancer Treatment and Research, 39)
82% match

Endocrine Therapies in Breast and Prostate Cancer: 39 (Cancer Treatment and Research, 39)

Springer

£120.73 15 Jun 2026
Breast Cancer: Origins, Detection, and Treatment: Proceedings of the International Breast Cancer Research Conference London, United Kingdom ― March 24–28, 1985: 43 (Developments in Oncology, 43)
82% match

Breast Cancer: Origins, Detection, and Treatment: Proceedings of the International Breast Cancer Research Conference London, United Kingdom ― March 24–28, 1985: 43 (Developments in Oncology, 43)

Springer

£77.95 25 May 2026
Omics Approaches in Breast Cancer: Towards Next-Generation Diagnosis, Prognosis and Therapy
81% match

Omics Approaches in Breast Cancer: Towards Next-Generation Diagnosis, Prognosis and Therapy

Springer

£74.05 05 Jun 2026
Breast Cancer, An Issue of Hematology/Oncology Clinics of North America (Volume 27-4) (The Clinics: Internal Medicine, Volume 27-4)
81% match

Breast Cancer, An Issue of Hematology/Oncology Clinics of North America (Volume 27-4) (The Clinics: Internal Medicine, Volume 27-4)

Elsevier

£55.48 21 May 2026
Early Onset Breast Cancer: Epidemiology, Pathobiology, Diagnosis, Treatment, and Survivorship
81% match

Early Onset Breast Cancer: Epidemiology, Pathobiology, Diagnosis, Treatment, and Survivorship

Springer

£129.99 25 May 2026
Improving Outcomes for Breast Cancer Survivors: Perspectives on Research Challenges and Opportunities: 862 (Advances in Experimental Medicine and Biology, 862)
81% match

Improving Outcomes for Breast Cancer Survivors: Perspectives on Research Challenges and Opportunities: 862 (Advances in Experimental Medicine and Biology, 862)

Springer

£78.95 28 May 2026
Endocrine Oncology (Contemporary Endocrinology)
81% match

Endocrine Oncology (Contemporary Endocrinology)

Humana

£73.10 27 May 2026
Resistance to Targeted Therapies in Breast Cancer: 16 (Resistance to Targeted Anti-Cancer Therapeutics, 16)
81% match

Resistance to Targeted Therapies in Breast Cancer: 16 (Resistance to Targeted Anti-Cancer Therapeutics, 16)

Springer

£80.62 29 May 2026
Environment and Breast Cancer
81% match

Environment and Breast Cancer

Springer

£107.98 12 Jun 2026
Breast Cancer: Nuclear Medicine in Diagnosis and Therapeutic Options
81% match

Breast Cancer: Nuclear Medicine in Diagnosis and Therapeutic Options

Springer

£49.69 06 Jun 2026
Breast Cancer: Progress in Biology, Clinical Management and Prevention: Proceedings of the International Association for Breast Cancer Research ... March 1989: 58 (Developments in Oncology, 58)
81% match

Breast Cancer: Progress in Biology, Clinical Management and Prevention: Proceedings of the International Association for Breast Cancer Research ... March 1989: 58 (Developments in Oncology, 58)

Springer

£121.32 05 Jun 2026